Navigation Links
Melanoma Less Common in Blacks But Deadlier
Date:12/23/2009

Skin cancer diagnosis occurs later in nonwhites, study finds

WEDNESDAY, Dec. 23 (HealthDay News) -- Doctors are diagnosing more white people with the deadly skin cancer known as melanoma, and while Hispanics and blacks are much less likely to be diagnosed with the malignancy, they often have advanced forms of the cancer when it is found, new research suggests.

"Research and public education efforts have focused on melanoma prevention in white populations because of their higher risk of developing melanoma," the study authors wrote in the December issue of the Archives of Dermatology. "Improved secondary prevention measures with earlier detection of thin [early-stage] melanoma likely account for the improved survival among whites from 68 percent in the early 1970s to 92 percent in recent years. Such advances, however, have not occurred in other racial and ethnic groups in the United States."

Researchers from the University of Miami Miller School of Medicine looked at statistics regarding 41,072 cases of melanoma between 1990 and 2004 from the Florida Cancer Data System. Almost all -- 39,670 -- were in non-Hispanic whites, with 1,148 in white Hispanics and 254 in blacks.

The Hispanic and black patients, however, had more advanced cases of melanoma, the study authors found. Eighteen percent of Hispanics and 26 percent of blacks had the most advanced kinds of cases, compared to 12 percent among non-Hispanic whites.

"Melanoma among darker-skinned populations has received little attention, partly reflecting their overall lower risk compared with white non-Hispanics," the authors noted. "The lowest survival rates and delayed melanoma diagnosis is often seen in blacks. With the readily expanding population and increasing melanoma rate of 2.9 percent per year, melanoma among Hispanics also becomes an increasingly important public health issue."

"This study adds to a growing body of literature that identifies a pervasive and persistent disparity in the stage of melanoma diagnosis between Hispanic and black patients versus white patients," wrote the authors of a commentary accompanying the study.

More information

Learn more about melanoma from the U.S. National Cancer Institute.



-- Randy Dotinga



SOURCE: JAMA/Archives journals, news release, Dec. 21, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Melanoma Diagnosis Often Delayed for Rural Poor
2. Melanoma drug revs immune cells but cancer cells ignore it
3. Promising drug combination may help those with ocular melanoma that has spread
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
6. New type of drug shows promise in attacking melanoma in an innovative way
7. Genes Unlock New Treatments for Deadly Melanoma
8. Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma
9. Researchers Hone in on Cancer Stem Cells for Melanoma
10. Melanomas may appear noticeably different than other moles
11. Melanomas Present Unique Appearance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy ... in the United States and Canada wear eyeglasses. Once considered to be a purely ... make a fashion statement. Even celebrities use glasses as a way of creating an ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
Breaking Medicine Technology: